Tegoprazan-amoxicillin dual therapy shows no difference in H. pylori eradication compared to bismuth quadruple therapy
Tegoprazan Dual Therapy Shows Similar Success for H. pylori Infection
This meta-analysis of randomized controlled trials involving 1541 participants found that 14-day tegoprazan-amoxicillin dual therapy had no …
A new 14-day dual therapy using tegoprazan and amoxicillin shows similar success rates to standard quadruple therapy for treating H. pylori …
Tegoprazan-amoxicillin dual therapy matches quadruple efficacy with fewer adverse events
Tegoprazan dual therapy matches standard H. pylori treatment
This systematic review and meta-analysis with trial sequential analysis compared tegoprazan-amoxicillin (TA) dual therapy with bismuth-conta…
A new review finds a simpler two-drug H. pylori treatment works as well as standard therapy, with fewer side effects.